Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6339748rdf:typepubmed:Citationlld:pubmed
pubmed-article:6339748lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C0019764lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:6339748lifeskim:mentionsumls-concept:C1708943lld:lifeskim
pubmed-article:6339748pubmed:issue3lld:pubmed
pubmed-article:6339748pubmed:dateCreated1983-5-27lld:pubmed
pubmed-article:6339748pubmed:abstractTextWe reviewed 77 potential cadaveric allograft recipients who had undergone prospective HLA-A and B locus and HLA-DR antigen identification. Matching was accomplished, giving first priority to HLA-DR compatibility and relying on HLA-A and B antigen matching only in situations of total HLA-DR incompatibility. Complete HLA-DR identification occurred in 56 per cent of all patients. There were 15 patients (19.5 per cent) who received a 2/2 HLA-DR perfect match, with 86.7 plus or minus 8.8 per cent 1-year actuarial graft survival, and 41 (53 per cent) who received a 1/2 HLA-DR match, with 58.2 plus or minus 7.8 per cent 1-year actual allograft survival. Finally, 21 patients (27 per cent) received a 0/2 HLA-DR match, with 64.9 plus or minus 10.7 per cent actual survival. These results and their mirrored mismatching results showed statistically significant allograft success in only the HLA-DR 2/2 matches. Matching for HLA 2 DR donors proved a statistically significant success over the other HLA-DR allograft matches and the older controversial matching system based on HLA-A and B locus antigens. The restricted gene polymorphism of the HLA-DR systems allows for a relatively high percentage of perfect HLA-DR matches.lld:pubmed
pubmed-article:6339748pubmed:languageenglld:pubmed
pubmed-article:6339748pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6339748pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6339748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6339748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6339748pubmed:statusMEDLINElld:pubmed
pubmed-article:6339748pubmed:monthMarlld:pubmed
pubmed-article:6339748pubmed:issn0022-5347lld:pubmed
pubmed-article:6339748pubmed:authorpubmed-author:SelaIIlld:pubmed
pubmed-article:6339748pubmed:authorpubmed-author:MendezRRlld:pubmed
pubmed-article:6339748pubmed:authorpubmed-author:IwakiYYlld:pubmed
pubmed-article:6339748pubmed:authorpubmed-author:BogaardTTlld:pubmed
pubmed-article:6339748pubmed:issnTypePrintlld:pubmed
pubmed-article:6339748pubmed:volume129lld:pubmed
pubmed-article:6339748pubmed:ownerNLMlld:pubmed
pubmed-article:6339748pubmed:authorsCompleteYlld:pubmed
pubmed-article:6339748pubmed:pagination481-3lld:pubmed
pubmed-article:6339748pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:meshHeadingpubmed-meshheading:6339748-...lld:pubmed
pubmed-article:6339748pubmed:year1983lld:pubmed
pubmed-article:6339748pubmed:articleTitleProspective HLA-DR matching in cadaveric renal transplants: a single center study.lld:pubmed
pubmed-article:6339748pubmed:publicationTypeJournal Articlelld:pubmed